Bryan Loy

Corporate Medical Director

Clinical Strategy


Bryan Loy MD, MBA is an industry recognized physician executive. He is a corporate medical director for Humana, a Fortune 1 health insurance company. Board certified in anatomic and clinical pathology and hematology, Dr. Loy currently leads Humana’s cancer care strategy, including quality and value initiatives for laboratory, medical oncology and radiation oncology.

He has 19+ years of experience in evaluating drugs and biologics, medical devices, laboratory tests, and innovations including both effectiveness and payment. He is well experienced in accelerating the appropriate adoption of new technology. He is an oncology and laboratory subject matter expert for pharmacy and therapeutics committees, policy development committees and recently completed his 3rd year as an advisor and co-chair for the Center for Medicare and Medicaid Services (CMS) advisory panel designed to evaluate appropriate payment for new complex lab tests. He works with the nation’s most prominent commercial labs and oncology groups to implement cancer quality initiatives in all 5 states. He collaborates directly with industry-leading medical oncologists and practices committed to improving the patient experience.

A nationally recognized speaker, panelist, and author, Dr. Loy routinely presents on innovative cancer initiatives, the evolving landscape of health care delivery and population health initiatives. He’s helped 1+ member employer groups understand medical cost and utilization and created strategies improving quality of care and value while improving the employee experience. He is co-chair for a large public-private partnership employing new population health technology combined with community collective impact initiatives to improve referral processes to agencies and resources that address social determinants of health.

In previous roles, he has served as a medical director for a multi-state Medicare contractor and as Chief Medical Officer for an innovative lab focused on tailoring treatment for breast and ovarian cancer patients.

Dr. Loy received his MBA (with distinction) from the University of Louisville and his MD from the University of Louisville. Dr. Loy continues to research and publish in population health, oncology, and molecular medicine.

Disclosures: Dr. Loy has no MCED-related relationships to disclose.